» Articles » PMID: 34400780

Astrocyte-derived TNF and Glutamate Critically Modulate Microglia Activation by Methamphetamine

Abstract

Methamphetamine (Meth) is a powerful illicit psychostimulant, widely used for recreational purposes. Besides disrupting the monoaminergic system and promoting oxidative brain damage, Meth also causes neuroinflammation, contributing to synaptic dysfunction and behavioral deficits. Aberrant activation of microglia, the largest myeloid cell population in the brain, is a common feature in neurological disorders triggered by neuroinflammation. In this study, we investigated the mechanisms underlying the aberrant activation of microglia elicited by Meth in the adult mouse brain. We found that binge Meth exposure caused microgliosis and disrupted risk assessment behavior (a feature that usually occurs in individuals who abuse Meth), both of which required astrocyte-to-microglia crosstalk. Mechanistically, Meth triggered a detrimental increase of glutamate exocytosis from astrocytes (in a process dependent on TNF production and calcium mobilization), promoting microglial expansion and reactivity. Ablating TNF production, or suppressing astrocytic calcium mobilization, prevented Meth-elicited microglia reactivity and re-established risk assessment behavior as tested by elevated plus maze (EPM). Overall, our data indicate that glial crosstalk is critical to relay alterations caused by acute Meth exposure.

Citing Articles

The interaction between central and peripheral immune systems in methamphetamine use disorder: current status and future directions.

Shi S, Sun Y, Zan G, Zhao M J Neuroinflammation. 2025; 22(1):40.

PMID: 39955589 PMC: 11829452. DOI: 10.1186/s12974-025-03372-z.


A ketogenic diet regulates microglial activation to treat drug addiction.

Ji J, Tang Y Front Pharmacol. 2025; 16:1462699.

PMID: 39917617 PMC: 11799558. DOI: 10.3389/fphar.2025.1462699.


Methamphetamine-mediated astrocytic pyroptosis and neuroinflammation involves miR-152-NLRP6 inflammasome signaling axis.

Oladapo A, Kannan M, Deshetty U, Singh S, Buch S, Periyasamy P Redox Biol. 2025; 80:103517.

PMID: 39879739 PMC: 11810843. DOI: 10.1016/j.redox.2025.103517.


Inflammaging and Brain Aging.

Jurcau M, Jurcau A, Cristian A, Hogea V, Diaconu R, Nunkoo V Int J Mol Sci. 2024; 25(19).

PMID: 39408862 PMC: 11476611. DOI: 10.3390/ijms251910535.


Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine.

Summers R, Fagiani F, Rowitch D, Absinta M, Reich D Trends Immunol. 2024; 45(10):799-813.

PMID: 39307583 PMC: 11471369. DOI: 10.1016/j.it.2024.08.004.


References
1.
Thanos P, Kim R, Delis F, Ananth M, Chachati G, Rocco M . Chronic Methamphetamine Effects on Brain Structure and Function in Rats. PLoS One. 2016; 11(6):e0155457. PMC: 4898739. DOI: 10.1371/journal.pone.0155457. View

2.
Chang X, Sun Y, Zhang Y, Muhai J, Lu L, Shi J . A Review of Risk Factors for Methamphetamine-Related Psychiatric Symptoms. Front Psychiatry. 2018; 9:603. PMC: 6251327. DOI: 10.3389/fpsyt.2018.00603. View

3.
Cadet J, Bisagno V, Milroy C . Neuropathology of substance use disorders. Acta Neuropathol. 2013; 127(1):91-107. PMC: 7453825. DOI: 10.1007/s00401-013-1221-7. View

4.
Northrop N, Halpin L, Yamamoto B . Peripheral ammonia and blood brain barrier structure and function after methamphetamine. Neuropharmacology. 2016; 107:18-26. PMC: 5264515. DOI: 10.1016/j.neuropharm.2016.03.018. View

5.
Shaerzadeh F, Streit W, Heysieattalab S, Khoshbouei H . Methamphetamine neurotoxicity, microglia, and neuroinflammation. J Neuroinflammation. 2018; 15(1):341. PMC: 6292109. DOI: 10.1186/s12974-018-1385-0. View